ArticlePloS one2025
Delineating SARS-CoV-2 spike protein and antibodies interaction interfaces via siamese neural networks: A geometric and image-based analysis.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The analysis of molecular interactions between antigens and antibodies is crucial for understanding the immunological mechanisms underlying the immune response and for developing effective therapies against various diseases. In this context, the ability to distinguish between protein interfaces that form stable and unstable complexes is a key step in the design of therapeutic antibodies and vaccines. In recent years, deep learning models have provided advanced tools for biomedical research. This work introduces a novel approach to analyzing antibody-antigen interactions, and in particular SARS-CoV-2 spike protein-targeting antibodies, using a Siamese Neural Network specifically designed to integrate depth maps with geometric descriptors of molecular surfaces. By combining these representations, the model captures geometrical shape complementarity to differentiate between stable and unstable protein complexes. The network was trained using image-based representations of antigens and antibodies interfaces enriched with geometric descriptors, using data that include binders and non-binders of the SARS-CoV-2 spike protein receptor-binding domain. The deep learning network operates by comparing feature vectors representing these molecular surfaces; pairs with closer vectors in feature space are associated with stable interactions, while those with more distant vectors suggest instability. Extensive testing with different configurations achieved an accuracy of 90%, demonstrating the robustness of this approach to predict interactions. This innovative integration of artificial intelligence, depth maps and geometric descriptors offers promising applications for designing novel antibodies and vaccines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.